IFN-α, produced mainly by plasmacytoid dendritic cells2,3, is known to be associated with disease activity, especially in lupus nephritis4 and anti-type I interferon receptor therapy has been shown to be efficient in SLE patients5. Here, IFNA17 is linked to systemic lupus erythematosus.